Ontology highlight
ABSTRACT: Context
Leptin replacement therapy improves metabolic complications in patients with lipodystrophy and severe hypoleptinemia (SH), but whether the response is related to the degree of hypoleptinemia remains unclear.Objective
The aim of the study was to compare efficacy of leptin therapy in familial partial lipodystrophy, Dunnigan variety (FPLD) patients with SH (serum leptin<7th percentile of normal) vs. those with moderate hypoleptinemia (MH; serum leptin in 7th to 20th percentiles).Design, setting, and patients
We conducted an open-label, parallel group, observational study in 14 SH (mean±sd, serum leptin, 1.9±1.1 ng/ml) and 10 MH (serum leptin, 5.3±1.0 ng/ml) women with FPLD.Intervention
Patients received 0.08 mg/kg·d of metreleptin by twice daily sc inje
SUBMITTER: Simha V
PROVIDER: S-EPMC3319219 | biostudies-literature | 2012 Mar
REPOSITORIES: biostudies-literature